Literature DB >> 23899630

Metabolic syndrome--from the neurotrophic hypothesis to a theory.

M G Hristova1.   

Abstract

Metabolic syndrome (MetS) is a complex and heterogeneous disease characterized by central obesity, impaired glucose metabolism, dyslipidemia, arterial hypertension, insulin resistance and high-sensitivity C-reactive protein. In 2006, a neurotrophic hypothesis of the etiopathogenesis of MetS was launched. This hypothesis considered the neurotrophins a key factor in MetS development. Chronic inflammatory and/or psychoemotional distress provoke a series of neuroimmunoendocrine interactions such as increased tissue and plasma levels of proinflammatory cytokines and neurotrophins, vegetodystonia, disbalance of neurotransmitters, hormones and immunity markers, activation of the hypothalamo-pituitary-adrenal axis, insulin resistance, and atherosclerosis. An early and a late clinical stage in the course of MetS are defined. Meanwhile, evidence of supporting results from the world literature accumulates. This enables the transformation of the definition of the neurotrophic hypothesis into a neurotrophic theory of MetS. The important role of two neurotrophic factors, i.e. the nerve growth factor and brain-derived neurotrophic factor as well as of the proinflammatory cytokines, neurotransmitters, adipokines and, especially, of leptin for the development of MetS, obesity and type 2 diabetes mellitus is illustrated. There are reliable scientific arguments that the metabotrophic deficit due to reduced neurotrophins could be implicated in the pathogenesis of MetS, type 2 diabetes mellitus, and atherosclerosis as well. A special attention is paid to the activity of the hypothalamo-pituitary-adrenal axis after stress. The application of the neurotrophic theory of MetS could contribute to the etiological diagnosis and individualized management of MetS by eliminating the chronic distress, hyponeurotrophinemia and consequent pathology. It helps estimating the risk, defining the prognosis and implementing the effective prevention of this socially significant disease as evidenced by the dramatic recent growth of the world publication output on this interdisciplinary topic.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23899630     DOI: 10.1016/j.mehy.2013.07.018

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

1.  A double-blind, rct testing beneficial modulation of BDNF in middle-aged, life style-stressed subjects: a clue to brain protection?

Authors:  D H Chui; M Marcellino; F Marotta; H Sweed; U Solimene; A I Vignali; W Xiao; A Ayala; U Cagnuolo; N Zerbinati
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  Investigation of the association between cardio-metabolic risk factors, neurotrophins and gastric hormones among apparently healthy women: A cross-sectional analysis.

Authors:  Reihaneh Zeinalian; Dorsa Arman Moghadam; Naseh Pahlavani; Neda Roshanravan; Mohammad Alizadeh; Masoumeh Jabbari; Sorayya Kheirouri
Journal:  J Cardiovasc Thorac Res       Date:  2022-03-06

3.  NT3/TrkC Pathway Modulates the Expression of UCP-1 and Adipocyte Size in Human and Rodent Adipose Tissue.

Authors:  María Bové; Fermi Monto; Paloma Guillem-Llobat; M Dolores Ivorra; M Antonia Noguera; Andrea Zambrano; M Salome Sirerol-Piquer; Ana Cristina Requena; Mauricio García-Alonso; Teresa Tejerina; José T Real; Isabel Fariñas; Pilar D'Ocon
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-18       Impact factor: 5.555

4.  The association between serum brain-derived neurotrophic factor and a cluster of cardiovascular risk factors in adolescents: The CHAMPS-study DK.

Authors:  Natascha Holbæk Pedersen; Jakob Tarp; Lars Bo Andersen; Anne Kær Gejl; Tao Huang; Lone Peijs; Anna Bugge
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

5.  Evaluation of Short and Long Term Cold Stress Challenge of Nerve Grow Factor, Brain-Derived Neurotrophic Factor, Osteocalcin and Oxytocin mRNA Expression in BAT, Brain, Bone and Reproductive Tissue of Male Mice Using Real-Time PCR and Linear Correlation Analysis.

Authors:  Claudia Camerino; Elena Conte; Roberta Caloiero; Adriano Fonzino; Mariarosaria Carratù; Marcello D Lograno; Domenico Tricarico
Journal:  Front Physiol       Date:  2018-01-11       Impact factor: 4.566

6.  Acute Effects of High Intensity, Resistance, or Combined Protocol on the Increase of Level of Neurotrophic Factors in Physically Inactive Overweight Adults: The BrainFit Study.

Authors:  María A Domínguez-Sanchéz; Rosa H Bustos-Cruz; Gina P Velasco-Orjuela; Andrea P Quintero; Alejandra Tordecilla-Sanders; Jorge E Correa-Bautista; Héctor R Triana-Reina; Antonio García-Hermoso; Katherine González-Ruíz; Carlos A Peña-Guzmán; Enrique Hernández; Jhonatan C Peña-Ibagon; Luis A Téllez-T; Mikel Izquierdo; Robinson Ramírez-Vélez
Journal:  Front Physiol       Date:  2018-06-27       Impact factor: 4.566

7.  Circulating Diabetic Candidate Neurotrophic Factors, Brain-Derived Neurotrophic Factor and Fibroblast Growth Factor 21, in Sleeve Gastrectomy.

Authors:  Hung-Hsuan Yen; Sung-Tsang Hsieh; Chi-Ling Chen; Wei-Shiung Yang; Po-Chu Lee; Ming-Tsan Lin; Chiung-Nien Chen; Po-Jen Yang
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.